XLV vs BIOY
YTDYear to date
Level
Past year
Level
Fee
XLV winslower fee
Yield
BIOY wins+32.1 pts
AUM
XLV31475.8× more
1–1level
XLV and BIOY · year-to-date · as of Nov 5, 2026 · AUM not scored
BIOY vs S&P 500
YTD$19.54 · +1.2% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D1M3MYTD ▼1Y3Y5YMAX
Total return+1.2%+2.0%+6.7%————+5.3%
Peer average+2.7%+8.5%+8.9%+24.4%+33.4%+84.3%+34.0%—
S&P 500 · VOO+1.6%−1.6%0.0%+13.4%+13.5%+91.7%+81.2%+831.3%
GraniteShares BIOY and Vanguard VOO · total return, dividends in · as of Nov 5, 2026
BIOY’s Holdings
Today[…] The fund reports no holdings yet.
All 39 Health Care ETFs
Today| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.3% | +24.0% | +3.1% | $49.1B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.3% | +23.3% | +3.1% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.3% | +30.6% | +2.7% | $10.6B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +23.7% | +3.3% | $4.9B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.2% | +19.7% | +3.2% | $4.7B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.4% | −2.7% | +6.7% | $4.1B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.1% | +23.4% | +3.1% | $3.5B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +71.5% | +0.4% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +29.8% | +2.2% | $1.7B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +27.1% | +1.9% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +26.0% | +2.8% | $1.2B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.6% | +36.8% | +2.3% | $1.2B | |
| 13 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +20.4% | +3.0% | $1.2B | |
| 14 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +26.8% | +4.1% | $1.2B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +26.9% | +1.9% | $579M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +38.2% | +2.4% | $538M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 5, 2026
BIOY Payouts by Year
1YLatest payout, Oct 2026
$0.23
a share · every week
33.5% yield
33.5% yield
1 years added up
$6.53 a share
$6.53 a share
GraniteShares BIOY · per-share distributions by ex-date · 2026–2026
BIOY’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.3% | +3.1% | +24.0% | +33.5% | $49.1B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.3% | +3.1% | +23.3% | +32.1% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.3% | +2.7% | +30.6% | +45.4% | $10.6B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | +3.3% | +23.7% | +32.8% | $4.9B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.2% | +3.2% | +19.7% | +28.6% | $4.7B | |
| 6 | BIOY | GraniteShares YieldBOOST Biotech ETFThis fund | 14.98% | 33.5% | +1.2% | new | new | $1.6M |
#39 cheapest of 39 · sorted by assetsOpen the Sectors table →
BIOY and its peer group · total return · as of Nov 5, 2026
Cards for This View
BIOY’s Top 10 Holdings
TodayBIOY reports no holdings we can show: […]
BIOY vs Peer Average
YTDBIOYAvsBPeer average
1D+1.2%+2.7%
1M+2.0%+8.5%
3M+6.7%+8.9%
YTD[…]+24.4%
1Y[…]+33.4%
3Y[…]+84.3%
5Y[…]+34.0%
0–3Peer average wins
38 Health care peers · each row scaled to its leader